Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what meetings representatives of (a) NICE and (b) NHS England have had with Roche on atezolizumab with nab-paclitaxel for breast cancer patients since the publication of NICE's draft guidance on that drug in October 2019.

NHS England and NHS Improvement has advised that it has met with Roche to discuss potential commercial arrangements for atezolizumab with nab-paclitaxel for breast cancer patients.

The National Institute for Health and Care Excellence (NICE) has advised that it held a telephone call with Roche on 23 January 2020 regarding atezolizumab with nab-paclitaxel for breast cancer patients and that it has been in contact with Roche by email since the publication of NICE's draft guidance in October 2019.